SSR182289A, a selective and potent orally active thrombin inhibitorJ.M. Altenburger, Jean‐Marc Herbert, J Lorrain et al.|Bioorganic & Medicinal Chemistry|2004Cited by 133
Antithrombotic Properties of SSR182289A, a New, Orally Active Thrombin InhibitorJ Lorrain, Stephen E. O'Connor, L. Millet et al.|Journal of Pharmacology and Experimental Therapeutics|2003Cited by 23
Effects of SanOrg123781A, a Synthetic Hexadecasaccharide, in a Mouse Model of Electrically Induced Carotid Artery Injury: Synergism with the Antiplatelet Agent ClopidogrelJ Lorrain, Jean‐Marc Herbert, Irène Lechaire et al.|Journal of Pharmacology and Experimental Therapeutics|2004Cited by 16
SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosisC. Visconte, J‐M. Herbert, J Lorrain et al.|Journal of Thrombosis and Haemostasis|2004Cited by 3